Laringal®
- Dosage form: Orodispersible tablets
- Dosage: 8.75 mg
- Registration number: RK-LS-5№024286
Laringal® -medicinal product for treatment of throat disease.
Medicinal product makes analgesic and anti-inflammatory effect to mucous tunic of mouth and throat: reduces edema, swallowing difficulty, pain and sensation of throat irritation.
Indications
- symptomatic treatment of pharyngalgia in inflammatory infections of mouth cavity and pharynx
Route of administration
For oral disintegrating. In is necessary to disintegrate tablet Laringal® in mouth until completely dissolved. When dissolving it is necessary to transfer the tablet all over mouth cavity to avoid mucous lining injury at place of disintegrating.
